{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:43Z","timestamp":1788910423813,"version":"build-2803163510"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"crossref","award":["C09.2287"],"award-info":[{"award-number":["C09.2287"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,11]]},"DOI":"10.1093\/infdis\/jiy010","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T18:09:13Z","timestamp":1516298953000},"page":"1462-1471","source":"Crossref","is-referenced-by-count":14,"title":["Protease-Activated Receptor 2 Facilitates Bacterial Dissemination in Pneumococcal Pneumonia"],"prefix":"10.1093","volume":"217","author":[{"given":"Florry E","family":"van den Boogaard","sequence":"first","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Center for Infection and Immunity Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xanthe","family":"Brands","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Center for Infection and Immunity Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JanWillem","family":"Duitman","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Center for Infection and Immunity Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha F","family":"de Stoppelaar","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Center for Infection and Immunity Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren S","family":"Borensztajn","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Inserm U700, Universit\u00e9 Paris Diderot, France"},{"name":"LabEx Inflamex, PRES Sorbonne Paris Cit\u00e9, France"},{"name":"Assistance Publique H\u00f4pitaux de Paris, DHU FIRE, Service de Pneumologie A, H\u00f4pital Bichat, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris J T H","family":"Roelofs","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morley D","family":"Hollenberg","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, University of Calgary, Faculty of Medicine, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Arnold","family":"Spek","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Center for Infection and Immunity Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J","family":"Schultz","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Intensive Care and Anesthesiology, The Netherlands"},{"name":"Department of Intensive Care Medicine, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"van \u2018t Veer","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Center for Infection and Immunity Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van der Poll","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine (CEMM), The Netherlands"},{"name":"Center for Infection and Immunity Amsterdam, The Netherlands"},{"name":"Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"key\n\t\t\t\t20180411032410_CIT0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2010.04.013","article-title":"Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia","volume":"36","author":"Jones","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180411032410_CIT0002","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180411032410_CIT0003","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pharmthera.2007.04.002","article-title":"A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors","volume":"115","author":"Sokolova","year":"2007","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20180411032410_CIT0004","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20180411032410_CIT0005","doi-asserted-by":"crossref","first-page":"24638","DOI":"10.1074\/jbc.M110.201988","article-title":"Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2)","volume":"286","author":"Ramachandran","year":"2011","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180411032410_CIT0006","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/18223","article-title":"A protective role for protease-activated receptors in the airways","volume":"398","author":"Cocks","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180411032410_CIT0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/pupt.2001.0285","article-title":"Protease-activated receptor-2 (PAR2) in the airways","volume":"14","author":"Cocks","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"key":"key\n\t\t\t\t20180411032410_CIT0008","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1242\/jcs.110.7.881","article-title":"Proteinase-activated receptor-2: expression by human neutrophils","volume":"110","author":"Howells","year":"1997","journal-title":"J Cell Sci"},{"key":"key\n\t\t\t\t20180411032410_CIT0009","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mai.2003.6","article-title":"Effect of acute and chronic inflammatory stimuli on expression of protease-activated receptors 1 and 2 in alveolar macrophages","volume":"111","author":"Roche","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t20180411032410_CIT0010","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.4049\/jimmunol.0803743","article-title":"Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway","volume":"182","author":"Khoufache","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180411032410_CIT0011","doi-asserted-by":"crossref","first-page":"L368","DOI":"10.1152\/ajplung.00036.2007","article-title":"Role of PAR2 in murine pulmonary pseudomonal infection","volume":"294","author":"Moraes","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key\n\t\t\t\t20180411032410_CIT0012","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ar.20846","article-title":"Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis","volume":"292","author":"Su","year":"2009","journal-title":"Anat Rec (Hoboken)"},{"key":"key\n\t\t\t\t20180411032410_CIT0013","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.shk.0000191385.41689.f3","article-title":"Pneumonia models and innate immunity to respiratory bacterial pathogens","volume":"24","author":"Knapp","year":"2005","journal-title":"Shock"},{"key":"key\n\t\t\t\t20180411032410_CIT0014","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180411032410_CIT0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1538-7836.2010.04089.x","article-title":"Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia","volume":"9","author":"Van Den Boogaard","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20180411032410_CIT0016","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/infdis\/jis290","article-title":"Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia","volume":"205","author":"van der Windt","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180411032410_CIT0017","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.172.5.3132","article-title":"Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense","volume":"172","author":"Knapp","year":"2004","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180411032410_CIT0018","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.1074\/jbc.M009116200","article-title":"Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2","volume":"276","author":"Bergum","year":"2001","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180411032410_CIT0019","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.CCM.0000218807.20570.C2","article-title":"Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia","volume":"34","author":"Rijneveld","year":"2006","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20180411032410_CIT0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1254\/jphs.92.420","article-title":"Nafamostat mesilate is an extremely potent inhibitor of human tryptase","volume":"92","author":"Mori","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"key\n\t\t\t\t20180411032410_CIT0021","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0898-6568(03)00014-7","article-title":"Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells","volume":"15","author":"Sendo","year":"2003","journal-title":"Cell Signal"},{"key":"key\n\t\t\t\t20180411032410_CIT0022","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1073\/pnas.1202641109","article-title":"CCAAT\/enhancer-binding protein \u03b4 facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner","volume":"109","author":"Duitman","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180411032410_CIT0023","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1538-7836.2011.04473.x","article-title":"Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram-negative sepsis (melioidosis)","volume":"9","author":"Kager","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20180411032410_CIT0024","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1254\/jphs.08162FP","article-title":"Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma","volume":"108","author":"Ishizaki","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"key\n\t\t\t\t20180411032410_CIT0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood-2013-03-488957","article-title":"Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3","volume":"122","author":"Burnier","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180411032410_CIT0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2007.07.011","article-title":"Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections","volume":"27","author":"Lim","year":"2007","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180411032410_CIT0027","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1073\/pnas.97.10.5255","article-title":"Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa","volume":"97","author":"Camerer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180411032410_CIT0028","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/infdis\/jiu285","article-title":"Mast cells impair host defense during murine Streptococcus pneumoniae pneumonia","volume":"210","author":"van den Boogaard","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180411032410_CIT0029","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1182\/blood-2010-01-257287","article-title":"Mast cell proteases: multifaceted regulators of inflammatory disease","volume":"115","author":"Pejler","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180411032410_CIT0030","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1074\/jbc.272.7.4043","article-title":"Interactions of mast cell tryptase with thrombin receptors and PAR-2","volume":"272","author":"Molino","year":"1997","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180411032410_CIT0031","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bjp.0705121","article-title":"A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium","volume":"138","author":"Sendo","year":"2003","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20180411032410_CIT0032","doi-asserted-by":"crossref","first-page":"L628","DOI":"10.1152\/ajplung.00046.2006","article-title":"PAR2 activation interrupts E-cadherin adhesion and compromises the airway epithelial barrier: protective effect of beta-agonists","volume":"291","author":"Winter","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key\n\t\t\t\t20180411032410_CIT0033","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.4049\/jimmunol.175.4.2598","article-title":"Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms","volume":"175","author":"Su","year":"2005","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180411032410_CIT0034","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/cc7026","article-title":"Tissue factor as an initiator of coagulation and inflammation in the lung","volume":"12","author":"van der Poll","year":"2008","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180411032410_CIT0035","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2353\/ajpath.2010.091107","article-title":"Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis","volume":"177","author":"Borensztajn","year":"2010","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180411032410_CIT0036","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"van der Poll","year":"2009","journal-title":"Lancet"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/217\/9\/1462\/24593243\/jiy010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T21:08:14Z","timestamp":1660338494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/217\/9\/1462\/4838378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,2,5]]},"published-print":{"date-parts":[[2018,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy010","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5,1]]},"published":{"date-parts":[[2018,2,5]]}}}